<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="44308">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02529475</url>
  </required_header>
  <id_info>
    <org_study_id>38RC14.428</org_study_id>
    <nct_id>NCT02529475</nct_id>
  </id_info>
  <brief_title>Evaluation of Inner Ear and Brain Structures With Contrast-enhanced MRI in Healthy Subjects (HYDROPS)</brief_title>
  <acronym>HYDROPS</acronym>
  <official_title>Evaluation of Inner Ear and Brain Structures With Contrast-enhanced MRI in Healthy Subjects (HYDROPS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Grenoble</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      -  This prospective study aims to better characterize inner ear's perilymphatic structures
           with Magnetic Resonance Imaging using contrast media and delayed injection in healthy
           subjects

        -  MR Perfusion Imaging will be assess in both cochlea as well

        -  Primary auditory brain pathways will be evaluated through MR diffusion imaging
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 2016</start_date>
  <completion_date type="Anticipated">September 2017</completion_date>
  <primary_completion_date type="Anticipated">September 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>No masking</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Gadolinium enhancement in inner ear structures as measured by MR T1 Weighted Imaging</measure>
    <time_frame>One MR scan (4 hours)</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Meniere Disease</condition>
  <arm_group>
    <arm_group_label>Gadoteric acid</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Gadoteric acid 0.2 mmol/kg</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Gadoteric acid</intervention_name>
    <description>Comparison with patients with Meniere's disease</description>
    <arm_group_label>Gadoteric acid</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Major subjects of over 50 years (mean age of Meniere's disease 40 to 50 years)

          -  Informed consent signed

          -  Medical examination performed prior to participation in research

          -  Patients without history of inner ear disease

          -  Recipient of a French social security scheme

        Exclusion Criteria:

          -  Patients minors

          -  Patients on a legal protection regime type guardianship

          -  Respiratory pathologies, cardiovascular, renal, diabetes

          -  Claustrophobia

          -  Contraindications to exposure to a magnetic field

          -  Contraindications to injecting Dotarem Â®
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arnaud ATTYE, PH</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Grenoble</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Arnaud ATTYE, PH</last_name>
    <phone>0033 476 763 450</phone>
    <email>aattye@chu-grenoble.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>GrenobleUniversityHospital</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arnaud ATTYE</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 9, 2017</lastchanged_date>
  <firstreceived_date>August 18, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Meniere Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
